Sentence examples for immunity pathways from inspiring English sources

Seth, R. B., Sun, L. & Chen, Z. J. Antiviral innate immunity pathways.

Finally, ER stress-induced unfolded protein response and innate immunity pathways are activated in ASI neurons to promote dauer diapause52,53.

Moreover, as mentioned above, the NF-κb-centered activation of innate immunity pathways play a determining oncogenic role in MDS and T-ALL15,21 T-ALL15,21

We hypothesize that the activation/deactivation of STAT2 can partially explain over/under expression of its targets which are mainly enriched in innate immunity pathways.

In conclusion, our analysis corroborated previous findings that innate immunity may be involved in the progression of PTSD, yet also identified candidate MRs driving the disease progression in the innate immunity pathways.

First, we show that activation of major innate immunity pathways, such as TLR1/2, TLR4 and TLR7/8, and infection with a live strain of IAV increase isoform diversity and elicit a marked remodelling of the isoform repertoire.

In the aspect of malignant hematopoiesis, an abnormally elevated JMJD3 level in association with an overactivated NF-κb/innate immunity pathway was documented in human CD34+ hematopoietic stem/progenitor cells of the myelodysplastic syndrome (MDS 15, a preleukemic state that may evolve into acute myeloid leukemia (AML) or acute lymphoid leukemia (ALL).

Plant cells defend against fungal attack through an innate immunity pathway in which infection triggers glucosinolate synthesis, stimulating formation of a protective callose.

INTERPRETATION Our hypothesis-generating data suggest the possibility that anti-inflammatory therapy with canakinumab targeting the interleukin-1β innate immunity pathway could significantly reduce incident lung cancer and lung cancer mortality.

There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P=0.Antiinflammatorytherapyerapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering.

One of the suppressors recovered in our genetic screen was the Tl receptor, which is a key component of the fly innate immunity pathway.